Dulaglutide for erectile dysfunction in type 2 diabetes
- PMID: 34153270
- DOI: 10.1016/S2213-8587(21)00142-X
Dulaglutide for erectile dysfunction in type 2 diabetes
Conflict of interest statement
SM is on advisory boards for AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk, Sanofi, and Bayer, receives speaker fees from AstraZeneca, Boehringer Ingelheim, Merck Sharp & Dohme, Novo Nordisk, and Sanofi, and has received research grants from Novo Nordisk and Boehringer Ingelheim.
Comment on
-
Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial.Lancet Diabetes Endocrinol. 2021 Aug;9(8):484-490. doi: 10.1016/S2213-8587(21)00115-7. Epub 2021 Jun 18. Lancet Diabetes Endocrinol. 2021. PMID: 34153269 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
